Valerio Therapeutics's market cap is currently €52.85M. The company's EPS TTM is €; its P/E ratio is -1.25; Valerio Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
